Educational information, not medical advice — ask your doctor or midwife.
Track Bromelain Enzyme (Topical) with reminders and record whether it helped, in the app.
Topical bromelain is a powerful enzyme preparation made from pineapple stem extract that is applied directly to the skin rather than swallowed. It works as a natural biological tool for clearing away damaged tissue, reducing swelling, and calming skin inflammation. Medical-grade topical bromelain products have been approved in some countries specifically for burn wound care, where they can remove dead tissue without surgery.
Bromelain's protease enzymes selectively break down proteins in dead, damaged, or inflamed tissue while largely leaving healthy tissue intact. This makes it especially useful for clearing burn eschar and wound debris — a process called enzymatic debridement. It also helps reduce swelling and redness by breaking down proteins involved in the inflammatory response and improving local circulation.
Topical bromelain is available as over-the-counter gels and creams for bruising and minor skin inflammation, and as high-concentration prescription-strength enzymatic debridement agents (such as NexoBrid, approved in the EU and US for burn care). The medical-grade concentrate delivers a much higher enzyme dose than consumer products.
Pineapple has been used in folk medicine across Central and South America for generations to soothe skin wounds and reduce swelling. Modern pharmaceutical development of topical bromelain for burn debridement accelerated in the early 2000s, culminating in EU approval of NexoBrid (concentrate of bromelain enriched in proteolytic enzymes) in 2012 and US FDA approval in 2020 for removing eschar in adults with deep partial- and full-thickness burns.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.